Unlike some of the managers I reviewed yesterday, Bruce Berkowitz and his cohorts at the Fairholme Capital have been buying. A scan of their Q3 2009 holdings spreadsheet suggests they favor healthcare companies and Berkshire Hathaway (BRK-A, BRK-B). Fairholme opened two new positions, both in the healthcare industry: Wyeth (WYE) and Cardinal Health (CAH). However, [...]
Meryl Witmer is back as it appears Eagle Value Partners is building its stock portfolio. If you have a strong case for other managers I should include, send me an email or post in the comments below. Also, keep in mind that I use a perl script to parse these filings into the spreadsheet format [...]
The Fairholme Fund have bounced back nicely in 2009, showing a 30% gain for the year. Quick summary follows but you can view Berkowitz’s portfolio moves in this spreadsheet. Their new positions seem to indicate that Berkowitz has changed his mind regarding some lukewarm comments about Berkshire Hathaway’s low growth potential a while back. He [...]
Meryl Witmer’s filing under Eagle Value Partners is puzzling as it contains only two stocks — I am unaware of any pertinent factors that may explain this filing so if readers have more knowledge than I, please clue us in. In any case, I have excluded Witmer’s filing but am please to bring back Marty [...]
Continuing the theme I discussed yesterday with Seth Klarman and Meryl Witmer’s filings, Bruce Berkowitz’s Fairholme Capital was strangely subdued (here’s the spreadsheet) despite the early March market plunge: As with Klarman and Witmer, no new positions added (according to the 13F — remember, incomplete information) despite new bear market lows. Instead, it seemed Berkowitz [...]
We continue our look at various money managers’ portfolios with Bruce Berkowitz of the Fairholme Fund. Readers can get a spreadsheet view of Berkowitz’s portfolio changes here. Notable changes include the following: Fairholme continues its thematic investing, opening or adding to bullish positions in defense and health insurers. New investments include Humana (HUM) and General [...]
